Comparably, in follicular thyroid cancer (FTC), the overexpression of Prospero homeobox 1 (PROX1), a key regulator of lymphangiogenesis, resulted in a decrease in several FGF signaling pathway members, including the downregulation of bFGF [162]. The gene discussed is PROX1; the disease is thyroid gland follicular carcinoma.